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a b s t r a c t
The nucleated polymerizationmodel is amathematical framework that has been applied to
aggregation and fragmentation processes in both the discrete and continuous settings. In
particular, thismodel has been the canonical framework for analyzing the dynamics of pro-
tein aggregates arising in prion and amyloid diseases such as Alzheimer’s and Parkinson’s
disease.
We present an explicit steady-state solution to the aggregate size distribution governed
by the discrete nucleated polymerization equations. Steady-state solutions have been pre-
viously obtained under the assumption of continuous aggregate sizes; however, the dis-
crete solution allows for direct computation and parameter inference, as well as facilitates
estimates on the accuracy of the continuous approximation.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Prion proteins are the cause underlying a host of fatal, mammalian diseases—including bovine spongiform encephalopa-
thy (mad cow disease), fatal familial insomnia, and Creutzfeldt–Jakob disease [1–3]. These diseases arise when a misfolded
(prion) form of a protein appears and forms aggregates. Aggregates of the misfolded form act as templates to convert the
normally folded protein to its misfolded state. Fragmentation of prion aggregates amplifies the number of templates fa-
cilitating the spread of the disease [4,5]. Beyond prions, linear protein aggregates (amyloids) are associated with over 20
neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease [6].
Since the formation of an initial stable nucleus of misfolded proteins is viewed as the time-limiting step in spontaneous
or genetic prion diseases, most mathematical models have focused on the time-evolution of the aggregate size distribution
[7,8]. The nucleated polymerization model [9] has been extensively analyzed and results on the existence, uniqueness, and
stability of solutions are known [10–12]; with a continuous relaxation on aggregate size, the asymptotic density is also
known [12,13]. While the continuous-size approximation is valid for large average aggregate sizes [14], this condition need
not apply to all prion systems [15].
Aggregates of protein monomers are discrete in nature and much can still be said regarding the original, discrete
formulation. We provide an explicit, closed-form solution for the steady-state distribution of discrete aggregate sizes. By
doing so, we consider the asymptotic aggregate dynamics without resorting to continuous approximations. The closed form
solution allows for explicit computation of statistics that may be useful for parameter inference. Finally, we compare our
discrete steady-state solution to the continuous approximation.
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2. Mathematical analysis of prion aggregation and fragmentation
2.1. Discrete nucleated polymerization model
The dynamics of prion aggregates are typicallymodeled by the nucleated polymerizationmodel first introduced byMasel
et al. [9]. In this model, normal protein is converted to the prion form through contact with existing aggregates. Existing
aggregates may also fragment into two smaller aggregates. The equations for the nucleated polymerization model may be
written as follows:
ds
dt
= α − µs(t)− 2βs(t)
∞
i=n0
ui(t)+ γ n0(n0 − 1)
∞
i=n0
ui(t) (1)
dui
dt
= −2βs[ui(t)− ui−1(t)] − µui(t)− γ (i− 1)ui(t)+ 2γ
∞
j=i+1
uj(t). (2)
Above, s(t) denotes the concentration of the healthy (non-prion) protein monomers, ui(t) the concentration of prion
aggregates of size i, n0 the minimum stable aggregate size (we write ui(t) ≡ 0 for i < n0), α the rate of translation of
monomers,µ the dilution or degradation rate, andβ the rate of conversion ofmonomers by prion aggregates. The parameter
γ describes the rate of aggregate fragmentation. In our formulation, we follow the conventional assumption that prion
aggregates are linear polymers and thus fragmentation may occur between any two prion monomers [9–12]. That is, if γ is
the rate of fragmentation between any two prion monomers, then the rate of fragmentation of an aggregate of size i ≥ n0
is γ (i− 1). (Note that alternative models for aggregate conversion and fragmentation have also been considered [14,16].)
The standard approach for analyzing the discrete nucleated polymerization model is to define auxiliary variables for the
zeroth and first moments of the aggregate sizes [1,9]. Let η =∞i=n0 ui and z =∞i=n0 iui. Then, the system will close over
the moments of the density:
ds
dt
= α − µs(t)− 2βs(t)η(t)+ γ n0(n0 − 1)η(t) (3)
dη
dt
= − [µ+ γ (2n0 − 1)] η(t)+ γ z(t) (4)
dz
dt
= 2βs(t)η(t)− µz(t)− γ n0(n0 − 1)η(t). (5)
This 3-dimensional system has two steady-state solutions, one corresponding to a disease-free state where all prion
aggregates are eliminated and one corresponding to persistence of the prion disease [11], i.e. an endemic equilibrium.
Furthermore, Prüss et al. [11] observed that the system can be transformed to a standard epidemiological model and found
the basic reproductive number,R0, that determines the stability of the disease. However, these results say little about the
density profile of aggregate sizes. Since this system has solutions that exist for all time, we treat s(t), η(t), and z(t) as known
functions and rewrite (2) as follows:
dui
dt
= −2βs(t)[ui(t)− ui−1(t)] − µui(t)− γ (i+ 1)ui(t)+ 2γ

η(t)−
i−1
j=n0
uj(t)

. (6)
Henceforth we consider only the system at equilibrium, i.e. when duidt = 0 for each i and dsdt = 0. We write s(t), η(t),
z(t), ui(t)→ s, η, z, ui as t →∞, where s = α/µ, η = z = 0 in the case of the disease-free state or
2βs
γ
=

n0 + µ
γ

n0 + µ
γ
− 1

,
z
η
= 2n0 − 1+ µ
γ
, s+ z = α
µ
, (7)
in the case of the endemic state.
2.2. Asymptotic distribution of aggregate sizes
Let ζ = n0 + µγ and define vi = (un0−1+i)/η and v0 = 0, w0 = 1. Though we divided by η, we treat this formally—our
result will still be valid in the disease-free case when η = 0. As observed by Masel et al. [9], the density will satisfy the
following recurrence relation:
vi =

ζ 2 − ζ  vi−1 + 2wi−1
ζ 2 + i , (8)
wi = wi−1 − vi. (9)
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Fig. 1. Density solution of the discrete nucleated polymerization equations, with parameter values from Tanaka et al. [17] (ζ = 101.25).
We instead consider the equivalent 2nd order recurrence relation:
0 = ζ 2 + i+ 2 vi+2 − 2ζ 2 − ζ + i− 1 vi+1 + ζ 2 − ζ  vi, (10)
where v0 = 0 and v1 = 21+ζ 2 . The solution to (10) is plotted in Fig. 1.
Our first contribution is an analysis of this 2nd order recurrence relation by finding its generating function. Other authors
have considered related recurrence relations but resort to its approximation by an ODE in order to obtain an approximate
solution [13]. We instead treat it exactly by defining f (x) =∞i=0 vixi; from (10), we obtain
f ′(x)+

ζ 2
x
+ 2
1− x − ζ (ζ − 1)

f (x) = 2
1− x , (11)
which has solution
f (x) = 2 (1− x)
2
xζ 2
eζ (ζ−1)x
 x
0
sζ
2
(1− s)3 e
−ζ (ζ−1)s ds. (12)
We refer the reader to the supplemental materials (see Appendix A) for the details, but after somemanipulation, we find
the power series for f (x) and determine
vm =

0 m = 0
2/(1+ ζ 2) m = 1
[2(ζ − 1)(2ζ + 1)]/[(ζ 2 + 1)(ζ 2 + 2)] m = 2
m(2ζ +m− 1) Γ (ζ
2)
Γ (ζ 2 +m+ 1) ζ
m(ζ − 1)m−1 m ≥ 3.
(13)
This yields um, the steady-state concentration of aggregates of sizem, since um = ηvm−n0+1.
3. Comparison to the continuous approximation
As mentioned earlier, an alternative approach to studying aggregate size dynamics is to approximate aggregate sizes
as continuous. This is a common approach to studying a broad class of ‘‘coagulation–fragmentation’’-like equations, and
generally speaking, the discrete system will converge to continuous system in the macroscopic limit; that is, as the average
aggregate cluster size gets larger. These results remain true under very general assumptions on the coagulation and
fragmentation terms of the model [18,19]. This analysis was done specifically for the nucleated polymerization equations
by Doumic et al. [14]. The scaling arguments in [14] yield weak convergence under more general modeling assumptions as
well as over time; we will show a stronger convergence, but only at steady-state and under the assumptions used to derive
our solutions.
Since ζ = n0 + µ/γ is the average size in our scaled, translated system of {vi}, we will study the limit ζ → ∞ in
relation to the continuous system solution, which we now describe. (We refer the reader to [10–12] for a full analysis of this
continuous model.)
The evolution of the continuous aggregate size distribution is governed by the following system of ordinary and partial
differential equations:
ds
dt
= α − µs(t)− 2βs(t)η(t)+ γ x20η(t) (14)
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dη
dt
= −[µ+ 2γ x0]η(t)+ γ z(t) (15)
dz
dt
= 2βs(t)η(t)− µz(t)− γ x20η(t) (16)
∂u
∂t
= −2βs(t) ∂u
∂x
− µu(t, x)− γ xu(t, x)+ 2γ
 ∞
x
u(t, y) dy. (17)
At steady-state, we have s = α/µ, η = z = 0 in the case of the disease-free state, or
2βs
γ
=

x0 + µ
γ
2
,
z
η
= 2x0 + µ
γ
, s+ z = α
µ
, (18)
and
0 = −2βs∂u
∂x
− µu(x)− γ xu(x)+ 2γ
 ∞
x
u(y) dy. (19)
in the case of the endemic equilibrium.
The analysis of Eq. (19) is specifically studied in Engler et al. [12]; we list the solution below (writing v(x) = u(x+x0)/η),
alongside our discrete solution:
vm = 1
ζ 2(ζ − 1)m(2ζ +m− 1)
Γ (ζ 2 + 1)
Γ (ζ 2 +m+ 1) (ζ (ζ − 1))
m , (20)
v(x) = 1
ζ 3
x(2ζ + x)e−
1
2ζ2
x(2ζ+x)
. (21)
Note that in (21) we set x0 = n0 so that ζ is the same in both the continuous and discrete cases. Assume m ≪ ζ 2 and
consider the following:
log
vm
v(m)
= − log

1− 1
ζ

+ log

1− 1
2ζ +m

+ m(2ζ +m)
2ζ 2
+m log

1− 1
ζ

−
m
i=1
log

1+ i
ζ 2

= 1
ζ
− 1
2ζ +m +
m(2ζ +m)
2ζ 2
− m
ζ
− 1
ζ 2
m
i=1
i+ O

m
ζ 2

= 1
ζ
− 1
2ζ +m + O

m
ζ 2

. (22)
Clearly then, as ζ →∞, vm → v(m). Treatingm as fixed, we have
 vm−v(m)v(m)  = O(1/ζ ), as demonstrated in Fig. 2. Finally,
to compare the actual aggregate density we need the asymptotic relationship between the continuous and discrete values
of η (denoted ηc and ηd, respectively). Let us also define κ = 2αβγµ . Then,
ηd
ηc
=

x0 + ζ
n0 − 1+ ζ

κ − ζ (ζ − 1)
κ − ζ 2

= 1+ O(1/ζ ). (23)
This yieldsum − u(m)u(m)
 =

ηd
ηc
vm−n0+1 − v(m− n0 + 1)
v(m− n0 + 1)
 = O(1/ζ ). (24)
Therefore, the continuous aggregate size distribution converges to the discrete distribution at a relative rate proportional to
O(ζ−1). This is without requiring a continuity correction, e.g. u(m) =  m+1/2m−1/2 u(x) dx.
4. Discussion and conclusions
Although continuous approximations of aggregate sizes are clearly useful, we anticipate that with increasing ability to
resolve aggregate sizes from atomic force microscopy [20], the discrete nature of protein aggregates are likely to become an
experimental reality. As such, the ability to consider discrete size distributions, will be important.
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(a)m versus aˆ, where aˆ is the least-squares estimate from the linear
model log2
 vm−v(m)v(m)  = a log2 ζ + b; here, log2 ζ is sampled uniformly in
[10, 25). This is roughly in agreement with our asymptotic estimate—the
slow increase in largem is due to violations of the assumption that
m/ζ 2 ≪ 1.
(b) log2 ζ versus log2
 vm−v(m)v(m) , form = 10 andm = 400. Notice that for
largem (dashed line), the scaling is not linear for small ζ . This effect is
what decreases the least-squares estimate in (a) and is remedied by
considering only ζ wherem/ζ 2 ≪ 1.
Fig. 2. Numerical verification of asymptotic error estimates.
Using generating functions, we determined a closed form for the aggregate size distribution at steady-state under the
nucleated polymerization model. With this solution, we were able to directly compare to the continuous relaxation and
establish stronger convergence than was previously known for the limit of large, average aggregate sizes (ζ = n0+µ/γ →
∞). We provide additional calculations for novel statistics of the discrete density (mode and variance) in the supplemental
materials (see Appendix A) that were also hitherto unknown; statistics that may facilitate parameter estimation.
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